B. Wayne Blount, MD, MPH
http://www.fpm.emory.edu/
Gene expression patterns in levodopa-induced dyskinesia
ftp://amusing.mit.edu/
Neural structures involved in the control of movement
http://www.cns.nyu.edu
Psychosis
http://www.pharmacology.Kartagener Syndrome: a relentless triad
Betsy Ott
http://www.uwec.edu/
Subluxation Definitions and Component Models
Victor G. Strang, D.C.
http://w3.palmer.edu/
Neuropsychological disorders
http://www.tamiu.edu/
Fluctuations in Parkinson’s Disease “From Tim Conway to Ray Charles”
Stephen G. Reich, M.D.
http://www.umm.edu
Treatment of Parkinson’s Disease
Christopher Buchanan
http://faculty.smu.edu
Pharmacodynamics of Antipsychotics Anxiolytics and
Sedative-Hypnotics
Yogesh Dwivedi, Ph.D.http://www.uic.edu/
Recent Research and Clinical Implications - Parkinson Disease
http://depts.washington.edu/
Basal Ganglia
http://www.kumc.edu/
400 free full text published articles
- No Association between PAWR Gene Polymorphisms and Tardive Dyskinesia in Schizophrenia Patients.
- Clinical aspects and management of levodopa-induced dyskinesia.
- Reversal of reserpine-induced orofacial dyskinesia and catalepsy by Nardostachys jatamansi.
- Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.
- Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats.
- L-745,870 reduces L-3,4-dihydroxyphenlylalanine-induced dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
- Phenytoin-induced acute orofacial dyskinesia.
- Two cases of primary ciliary dyskinesia with different responses to macrolide treatment.
- Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.
- Somatosensory disinhibition in patients with paroxysmal kinesigenic dyskinesia.
- Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.
- Mutations in radial spoke head genes and ultrastructural cilia defects in East-European cohort of primary ciliary dyskinesia patients.
- Relevance of animal models to human tardive dyskinesia.
- Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.
- Primary Ciliary Dyskinesia in Children: A Review for Pediatricians, Allergists, and Pediatric Pulmonologists.
- Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.
- Ultrastructural pathology of primary ciliary dyskinesia: report about 125 cases in Germany.
- L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.
- Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.
- Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease.
- Rapid response of disabling tardive dyskinesia to amantadine: a case report.
- The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.
- Development and validation of a method of cilia motility analysis for the early diagnosis of primary ciliary dyskinesia.
- Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia.
- Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.
- L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.
- Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats.
- Characterization of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers in vitro and in the MPTP-lesioned primate: R-MDMA reduces severity of dyskinesia, whereas S-MDMA extends duration of ON-time.
- Primary ciliary dyskinesia: evaluation using cilia beat frequency assessment via spectral analysis of digital microscopy images.
- Reversible oral dyskinesia associated with quetiapine in an adolescent: a case-report.
- No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients.
- Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients.
- Optic nerve projections in patients with primary ciliary dyskinesia.
- Primary ciliary dyskinesia caused by homozygous mutation in DNAL1, encoding dynein light chain 1.
- Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability.
- Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
- Analyzing clinical and electrophysiological characteristics of Paroxysmal Dyskinesia.
- Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia phenotypes of genomic Cacna1a mutations.
- Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.
- The role of glyoxalases for sugar stress and aging, with relevance for dyskinesia, anxiety, dementia and Parkinson's disease.
- [Tako-tsubo syndrome. Transient left ventricular dyskinesia. Presentation of our casuistics].
- Lingual dyskinesia and tics: a novel presentation of copper-metabolism disorder.
- A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole.
- Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice.
- Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia.
- Population specificity of the DNAI1 gene mutation spectrum in primary ciliary dyskinesia (PCD).
- Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia.
- Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.
- Otologic features in children with primary ciliary dyskinesia.
- Infantile convulsions with paroxysmal dyskinesia (ICCA syndrome) and copy number variation at human chromosome 16p11.
- Oxcarbazepine-induced tardive dyskinesia: A rare adverse reaction.
- [GRK6, a new therapeutic approach to alleviate L-dopa-induced dyskinesia].
- Basal Ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia.
- Deletion of adenosine A₁ or A(₂A) receptors reduces L-3,4-dihydroxyphenylalanine-induced dyskinesia in a model of Parkinson's disease.
- Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia.
- Mitochondrial abnormalities in the putamen in Parkinson's disease dyskinesia.
- Gradual onset of dyskinesia induced by mirtazapine.
- Primary ciliary dyskinesia demonstrating atypical presentation of Kartagener's syndrome.
- Maladaptive striatal plasticity in L-DOPA-induced dyskinesia.
- Primary ciliary dyskinesia that responded to long-term, low-dose clarithromycin.
- Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
- An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing.
- Ciliated air-liquid cultures as an aid to diagnostic testing of primary ciliary dyskinesia.
- Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA-induced dyskinesia in rats.
- Dysphagia due to tardive dyskinesia.
- mTORC1 signaling in Parkinson's disease and L-DOPA-induced dyskinesia: A sensitized matter.
- Characteristics of chloride transport in nasal mucosa from patients with primary ciliary dyskinesia.
- Factors influencing age at diagnosis of primary ciliary dyskinesia in European children.
- Relapse of tardive dyskinesia due to reduction in clozapine dose.
- New DNAH11 mutations in primary ciliary dyskinesia with normal axonemal ultrastructure.
- Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease.
- [Familial idiopathic paroxysmal kinesigenic dyskinesia: its natural history and a descriptive study in three Spanish families].
- Primary ciliary dyskinesia in Amish communities.
- Direct relief of levodopa-induced dyskinesia by stimulation in the area above the subthalamic nucleus in a patient with Parkinson's disease--case report.
- [Value of nasal nitric oxide in the diagnosis of primary ciliary dyskinesia].
- Familial Paroxysmal Kinesigenic Dyskinesia.
- Familial Paroxysmal Nonkinesigenic Dyskinesia.
- Primary Ciliary Dyskinesia.
- Reduction of L-DOPA-induced dyskinesia by the selective metabotropic glutamate receptor 5 antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease.
- Dyskinesia and the antiparkinsonian response always temporally coincide: a retrospective study.
- Objective measurement of dyskinesia in Parkinson's disease using a force plate.
- Lung function in patients with primary ciliary dyskinesia: a cross-sectional and 3-decade longitudinal study.
- Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study.
- Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.
- Founder mutation(s) in the RSPH9 gene leading to primary ciliary dyskinesia in two inbred Bedouin families.
- Amoxapine-induced tardive dyskinesia.
- No Evidence for Association between Tyrosine Hydroxylase Gene Val81Met Polymorphism and Susceptibility to Tardive Dyskinesia in Schizophrenia.
- Sphincter of Oddi dysfunction: psychosocial distress correlates with manometric dyskinesia but not stenosis.
- Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children.
- Loss-of-function mutations in the human ortholog of Chlamydomonas reinhardtii ODA7 disrupt dynein arm assembly and cause primary ciliary dyskinesia.
- Deletions and point mutations of LRRC50 cause primary ciliary dyskinesia due to dynein arm defects.
- Diagnostic testing of patients suspected of primary ciliary dyskinesia.
- Anatomic localization of dyskinesia in children with "profound" perinatal hypoxic-ischemic injury.
- A 20-year experience of electron microscopy in the diagnosis of primary ciliary dyskinesia.
- Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E.
- [Primary ciliary dyskinesia. Ciliopathies].
- Health-related quality of life and unmet needs in patients with primary ciliary dyskinesia.
- Conditional deletion of dnaic1 in a murine model of primary ciliary dyskinesia causes chronic rhinosinusitis.
- Lung disease assessment in primary ciliary dyskinesia: a comparison between chest high-field magnetic resonance imaging and high-resolution computed tomography findings.
- Disrupted ciliated epithelium shows slower ciliary beat frequency and increased dyskinesia.
- Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease.
- Primary ciliary dyskinesia.
- Primary ciliary dyskinesia: Myths and realities.
- Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia.
- Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling.
- Mortality and tardive dyskinesia: long-term study using the US National Death Index.
- The role of the dorsal raphe nucleus in the development, expression, and treatment of L-dopa-induced dyskinesia in hemiparkinsonian rats.
- Tardive dyskinesia following risperidone treatment in Tourette's syndrome.
- Levodopa-induced dyskinesia and striatal signaling pathways.
- {beta} subunit-specific modulations of BK channel function by a mutation associated with epilepsy and dyskinesia.
- Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities.
- Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence.
- Motor worsening and tardive dyskinesia with aripiprazole in Lewy body dementia.
- Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
- [Transient midventricular dyskinesia: tako-tsubo cardiomyopathy. The story continues].
- Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.
- Familial dyskinesia and facial myokymia (FDFM): Follow-up of a large family and linkage to chromosome 3p21-3q21.
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
- DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm.
- Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease?
- Successful twin birth following blastocyst culture of embryos derived from the immotile ejaculated spermatozoa from a patient with primary ciliary dyskinesia: a case report.
- Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
- Mutation of murine adenylate kinase 7 underlies a primary ciliary dyskinesia phenotype.
- Exogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.
- Myocardial cell membrane stress ionic dyskinesia reversal by diltiazem.
- Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.
- Structural and functional lung disease in primary ciliary dyskinesia.
- Botulinum toxin type A in the healing of ulcer following oro-mandibular dyskinesia in a patient in a vegetative state.
- [Transient left midventricular dyskinesia: clinical features of a new variant].
- Increase in the effectiveness of somatodendritic 5-HT-1A receptors in a rat model of tardive dyskinesia.
- Placebo influences on dyskinesia in Parkinson's disease.
- Aripiprazole (abilify) and tardive dyskinesia.
- RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease.
- [Clinical and ultrastructural features of ciliary dyskinesia].
- Primary ciliary dyskinesia in mice lacking the novel ciliary protein Pcdp1.
- Heterotaxy and complex structural heart defects in a mutant mouse model of primary ciliary dyskinesia.
- Primary ciliary dyskinesia: considerations regarding six cases of Kartagener syndrome.
- An interview with Jeffrey A. Lieberman: Tardive Dyskinesia. [interview by Sussman Norman].
- [An 81-year-old female with paroxysmal dyskinesia of the tongue].
- Evaluating the cost-effectiveness of reduced tardive dyskinesia with second-generation antipsychotics.
- Sporadic paroxysmal non-kinesigenic dyskinesia: a frequently-misdiagnosed movement disorder.
- Improvement of chronic facial pain and facial dyskinesia with the help of botulinum toxin application.
- Worsening of tardive dyskinesia due to clozapine therapy.
- Diagnosing primary ciliary dyskinesia.
- Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.
- Pulmonary radioaerosol mucociliary clearance in diagnosis of primary ciliary dyskinesia.
- Primary ciliary dyskinesia: current state of the art.
- Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia.
- Theophylline, adenosine receptor antagonist prevents behavioral, biochemical and neurochemical changes associated with an animal model of tardive dyskinesia.
- Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment.
- Chiropractic management of musculoskeletal pain secondary to tardive dyskinesia.
- Heterotaxia, congenital heart disease, and primary ciliary dyskinesia.
- Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia.
- Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease.
- Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
- High-resolution CT of patients with primary ciliary dyskinesia.
- Diagnosis of common variable immunodeficiency in a patient with primary ciliary dyskinesia.
- A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia.
- Nasal nitric oxide in atypical primary ciliary dyskinesia.
- Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: role of oxidative stress pathway genes.
- Carrier status for 3 most frequent CFTR mutations in Polish PCD/KS patients: lack of association with the primary ciliary dyskinesia phenotype.
- Management of conventional antipsychotic-induced tardive dyskinesia.
- [Dose reduction of conventional antipsychotics: does it reduce tardive dyskinesia?].
- [Aborted sudden death secondary to recurrent transient apical dyskinesia].
- Forebrain adenosine A2A receptors contribute to L-3,4-dihydroxyphenylalanine-induced dyskinesia in hemiparkinsonian mice.
- Normalization and expression changes in predefined sets of proteins using 2D gel electrophoresis: a proteomic study of L-DOPA induced dyskinesia in an animal model of Parkinson's disease using DIGE.
- Living with primary ciliary dyskinesia: a prospective qualitative study of knowledge sharing, symptom concealment, embarrassment, mistrust, and stigma.
- Endothelial proliferation and increased blood-brain barrier permeability in the basal ganglia in a rat model of 3,4-dihydroxyphenyl-L-alanine-induced dyskinesia.
- In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
- [Lithoptysis in a patient with primary ciliary dyskinesia].
- A case of choreoacanthocytosis with marked weight loss: impact of orolingual dyskinesia.
- Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation.
- Movement: the emerging genetics of primary ciliary dyskinesia.
- Aripiprazole-related tardive dyskinesia.
- Ear dyskinesia.
- Nasal nitric oxide to diagnose primary ciliary dyskinesia in newborns.
- DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects.
- A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia.
- Marked improvement in chronic tardive dyskinesia after changing to aripiprazole.
- Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
- Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances.
- Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis.
- Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.
- Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia.
- RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa.
- Functional analysis of tardive dyskinesia: implications for assessment and treatment.
- Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
- Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes.
- A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease.
- Mucociliary transport using 99mTc-albumin colloid: a reliable screening test for primary ciliary dyskinesia.
- Identification and analysis of axonemal dynein light chain 1 in primary ciliary dyskinesia patients.
- Resolution of Ziprasidone-Related Tardive Dyskinesia With a Switch to Aripiprazole.
- Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia.
- Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
- Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia.
- Tardive dyskinesia in 2 patients treated with ziprasidone.
- Molecular diagnosis of pseudohypoparathyroidism type Ib in a family with presumed paroxysmal dyskinesia.
- Abnormal cortical and spinal inhibition in paroxysmal kinesigenic dyskinesia.
- Handedness and situs inversus in primary ciliary dyskinesia.
- Analogue functional analysis of movements associated with tardive dyskinesia.
- Nasal nitric oxide is low early in life: case study of two infants with primary ciliary dyskinesia.
- Orolingual dyskinesia in central pontine myelinolysis.
- Living with primary ciliary dyskinesia (PCD).
- The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway.
- Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia.
- Nasal nitric oxide: clue to a diagnosis of ciliary dyskinesia.
- Risperidone and olanzapine induced tardive dyskinesia : a critical review of reported cases.
- Clinical and familial correlates of tardive dyskinesia in India and Israel.
- Primary ciliary dyskinesia: genes, candidate genes and chromosomal regions.
- Risperidone improves severe tardive dyskinesia in people with schizophrenia.
- Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia.
- Paroxysmal kinesigenic dyskinesia manifestation of hyperthyroidism.
- A Case Report of Methylphenidate-Induced Dyskinesia.
- Loci for primary ciliary dyskinesia map to chromosome 16p12.1-12.2 and 15q13.1-15.1 in Faroe Islands and Israeli Druze genetic isolates.
- Central microtubular agenesis causing primary ciliary dyskinesia.
- Apparent X-linked primary ciliary dyskinesia associated with retinitis pigmentosa and a hearing loss.
- Cerebrotendinous xanthomatosis with oromandibular dyskinesia.
- Clinical, molecular, and PET study of a case of aceruloplasminaemia presenting with focal cranial dyskinesia.
- Duration of amantadine benefit on dyskinesia of severe Parkinson's disease.
- "Neck Dyskinesia With Olanzapine-a case report".
- Primary ciliary dyskinesia: diagnostic and phenotypic features.
- [Primary ciliary dyskinesia in children]
- Primary ciliary dyskinesia as a cause of neonatal respiratory distress: implications for the neonatologist.
- Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impact.
- Investigation of the possible role of a novel gene, DPCD, in primary ciliary dyskinesia.
- Atypical antipsychotics and tardive dyskinesia.
- Neuroleptic drug exposure and incidence of tardive dyskinesia: a records-based case-control study.
- 3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates.
- Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia.
- Spontaneous dyskinesia in first-degree relatives of chronically ill, never-treated people with schizophrenia.
- Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene.
- Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients.
- Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics.
- Chemotaxis of blood neutrophils from patients with primary ciliary dyskinesia.
- [Pyridoxine in the management of tardive dyskinesia].
- Nasal nitric oxide measurements for the screening of primary ciliary dyskinesia.
- Comparison of exhaled and nasal nitric oxide and exhaled carbon monoxide levels in bronchiectatic patients with and without primary ciliary dyskinesia.
- Olanzepine-induced tardive dyskinesia.
- Abnormal movements and tardive dyskinesia in smokers and nonsmokers with schizophrenia genotyped for cytochrome P450 2D6.
- Primary ciliary dyskinesia.
- Risperidone induced tardive dyskinesia - a case report.
- Association of a polymorphism in the promoter region of the serotonin 5-HT2C receptor gene with tardive dyskinesia in patients with schizophrenia.
- Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up.
- Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia.
- Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
- Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms.
- Short and long term prognostic importance of regional dyskinesia versus akinesia in acute myocardial infarction.
- Freeze fracture study of airway epithelium from patients with primary ciliary dyskinesia.
- Loss of function of axonemal dynein Mdnah5 causes primary ciliary dyskinesia and hydrocephalus.
- Mutations in DNAI1 (IC78) cause primary ciliary dyskinesia.
- Identification of dynein heavy chain 7 as an inner arm component of human cilia that is synthesized but not assembled in a case of primary ciliary dyskinesia.
- Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia.
- Neurodevelopmental origins of tardivelike dyskinesia in schizophrenia patients and their siblings.
- Tardive dyskinesia--diagnostic issues, subsyndromes, and concurrent movement disorders: a study of state hospital inpatients referred to a movement disorder consultation service.
- Germline mutations in an intermediate chain dynein cause primary ciliary dyskinesia.
- Tetrabnazine for isolated shoulder tardive dyskinesia.
- Increased ictal perfusion of the thalamus in paroxysmal kinesigenic dyskinesia.
- Primary ciliary dyskinesia syndrome associated with abnormal ciliary orientation in infants.
- [Primary ciliary dyskinesia. report of three cases].
- Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia.
- Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
- Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome).
- Risperidone - induced tardive dyskinesia : case report and review of literature.
- Homozygosity mapping of a gene locus for primary ciliary dyskinesia on chromosome 5p and identification of the heavy dynein chain DNAH5 as a candidate gene.
- Paroxysmal non-kinesigenic dyskinesia: pathophysiological investigations.
- Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
- Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease.
- Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats.
- Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome.
- A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.
- Risperidone implicated in the onset of tardive dyskinesia in a young woman.
- Primary ciliary dyskinesia associated with a novel microtubule defect in a child with Down's syndrome.
- Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity.
- A locus for primary ciliary dyskinesia maps to chromosome 19q.
- The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia.
- Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E.
- An ambulatory dyskinesia monitor.
- Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia.
- Educational video: primary ciliary dyskinesia-How to treat it and live with it
- Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia.
- A possible mechanism of primary ciliary dyskinesia: a case of a segmental defect in ciliary microtubules.
- Effect of aerosolized uridine-5'-triphosphate on airway clearance with cough in patients with primary ciliary dyskinesia.
- Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia.
- Thalamotomy for severe antipsychotic induced tardive dyskinesia and dystonia.
- Exclusion of chromosome 7 for Kartagener syndrome but suggestion of linkage in families with other forms of primary ciliary dyskinesia.
- Spontaneous dyskinesia in first episode schizophrenia.
- Primary ciliary dyskinesia: diagnosis and standards of care.
- Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease.
- Airway response of children with primary ciliary dyskinesia to exercise and beta2-agonist challenge.
- Neurobiological characterization of bipolar affective disorders : a focus on tardive dyskinesia and soft neurological signs in relation to serum dopamine Beta hydroxylase activity.
- Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
- Longitudinal study of lung function in a cohort of primary ciliary dyskinesia.
- Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin.
- Bilateral posteroventral pallidotomy for severe antipsychotic induced tardive dyskinesia and dystonia.
- [Neuroleptic medication and the risk of tardive dyskinesia: a survey of psychiatrists and general practitioners in Quebec].
- Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients.
- Gallbladder dyskinesia in children.
- Treatment of tardive dyskinesia.
- Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism.
- A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q.
- Is resection of bronchiectasis beneficial in patients with primary ciliary dyskinesia?
- The moving ear syndrome: a focal dyskinesia.
- Pesistent parkinsonism and tardive dyskinesia.
- Successful treatment of intractable tardive dyskinesia with botulinum toxin.
- Fertility in men with primary ciliary dyskinesia presenting with respiratory infection.
- Unusual inheritance of primary ciliary dyskinesia (Kartagener's syndrome).
- Respiratory dyskinesia. An underrecognized phenomenon.
- Risk factors for tardive dyskinesia.
- Is the social acceptability of psychiatric patients decreased by orofacial dyskinesia?
- Respiratory dysrhythmias in patients with tardive dyskinesia.
- Ciliary disorientation: a possible variant of primary ciliary dyskinesia.
- Vitamin E in the treatment of tardive dyskinesia.
- Tardive dyskinesia.
- Tardive dyskinesia presenting as severe dysphagia.
- Primary ciliary dyskinesia.
- Intracavitary repair of ventricular aneurysm and regional dyskinesia.
- Gender differences in tardive dyskinesia: a critical review of the literature.
- Primary ciliary dyskinesia.
- Neutrophil function in dogs with congenital ciliary dyskinesia.
- Dickens, dystonia and dyskinesia.
- Neuroleptics and tardive dyskinesia--a case of iatrogenesis.
- Tardive dyskinesia.
- Mucociliary clearance from central airways in patients with excessive sputum production with and without primary ciliary dyskinesia.
- Tardive dyskinesia successfully treated with alprazolam.
- Sulpiride in tardive dyskinesia.
- Tardive dyskinesia: a potential new neurochemical animal model.
- Low dose levodopa in tardive dyskinesia.
- Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
- Respiratory failure due to vocal cord dyskinesia in olivo-ponto-cerebellar atrophy.
- Dyskinesia in the elderly presenting as respiratory disorder.
- Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
- Orientation of respiratory tract cilia in patients with primary ciliary dyskinesia, bronchiectasis, and in normal subjects.
- Mortality rate of schizophrenic patients with tardive dyskinesia during 10 years: a controlled study.
- Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.
- Chronic pneumonia in a child with primary ciliary dyskinesia.
- Tardive dyskinesia.
- Tardive dyskinesia.
- Tardive dyskinesia.
- Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.
- Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
- The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies.
- Impaired sensorimotor integration in parkinsonism and dyskinesia: a role for corollary discharges?
- Role of the basal ganglia and cerebral cortex in tardive dyskinesia: evidence from cerebrovascular accident.
- Paradoxical response of sphincter of Oddi to intravenous injection of cholecystokinin or ceruletide. Manometric findings and results of treatment in biliary dyskinesia.
- The irregularly irregular pattern of respiratory dyskinesia.
- Episodic laryngeal dyskinesia. Clinical and psychiatric characterization.
- Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
- Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.
- Abnormal eye-head coordination in Parkinson's disease patients after administration of levodopa: a possible substrate of levodopa-induced dyskinesia.
- Tardive dyskinesia associated with metoclopramide.
- A trial of sodium valproate in tardive-dyskinesia.
- Minimization and overreaction to tardive dyskinesia.
- Anosognosia in tardive dyskinesia: "tardive dysmentia" or "tardive dementia"?
- A 10-year follow-up study of tardive dyskinesia--with special reference to the influence of neuroleptic administration on the long-term prognosis.
- Nomifensine-induced dyskinesia.
- Persistent akathisia associated with early dyskinesia.
- Metoclopramide and tardive dyskinesia in the elderly.
- Primary ciliary dyskinesia.
- Levodopa-induced dyskinesia and thalamotomy.
- A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
- Hydrocephalus and primary ciliary dyskinesia.
- A case of tardive dyskinesia caused by metoclopramide.
- Persistent akathisia associated with early tardive dyskinesia.
- Tardive dyskinesia associated with metoclopramide.
- Tardive dyskinesia: clinical correlation with computed tomography in patients aged less than 60 years.
- Ciliary dyskinesia with normal ultrastructure.
- Sustained levodopa therapy in tardive dyskinesia.
- State-dependent tardive dyskinesia in manic-depressive illness.
- Metoclopramide in tardive dyskinesia.
- Tardive dyskinesia in a nonpsychiatric patient due to short-term use of a neuroleptic/anticholinergic combination drug.
- Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
- Dyskinesia induced by mefanimic acid?
- Cystic fibrosis ciliary dyskinesia substances and pulmonary disease. Effects of ciliary dyskinesia substances on neutrophil movement in vitro.
- Tardive dyskinesia.
- Use of propranolol in treating tardive dyskinesia.
- Tardive dyskinesia.
- Psychiatry-epitomes of progress: tardive dyskinesia.
- Symptomatic treatment of tardive dyskinesia: a word of caution.
- The use of propranolol in treating tardive dyskinesia.
- Synthesis and secretion of cystic fibrosis ciliary dyskinesia substances by purified subpopulations of leukocytes.
- Treatment of tardive dyskinesia with choline and tetrabenazine.
- Clinical aspects of dyskinesia.
- Oxiperomide in tardive dyskinesia.
- Tardive dyskinesia.
- Tardive dyskinesia treated with clonidine.
- Neuroleptic plasma levels and tardive dyskinesia.
- Neuroleptic plasma levels and tardive dyskinesia: a possible link?
- Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
- Tardive dyskinesia.
- The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].
- Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia.
- Methodological issues in tardive dyskinesia research.
- In search of treatment for tardive dyskinesia: review of the literature.
- Depot fluphenazine and tardive dyskinesia.
- Sodium valproate in the treatment of levodopa-induced dyskinesia.
- Phenobarbital dyskinesia.
- Tardive dyskinesia associated with metoclopramide.
- Tardive dyskinesia treated with manganese.
- Tardive dyskinesia treated with deanol acetamidobenzoate.
- Tardive dyskinesia and pimozide.
No comments:
Post a Comment
Your comment will appear after it is approved